Xtx Topco LTD Theravance Biopharma, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 16,356 shares of TBPH stock, worth $153,582. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,356
Previous 20,439
19.98%
Holding current value
$153,582
Previous $164,000
6.71%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding TBPH
# of Institutions
129Shares Held
46.5MCall Options Held
600Put Options Held
300-
Madison Avenue Partners, LP New York, NY9.51MShares$89.3 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$70 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$44.7 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$35.5 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.9 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $627M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...